Lancet urges EC approval
This article was originally published in The Tan Sheet
Executive Summary
Acting FDA Commissioner Andrew von Eschenbach, MD, should take an independent stand in the face of political pressure and approve Barr Pharmaceuticals Rx-to-OTC switch application for Plan B emergency contraceptive, according to an editorial in The Lancet May 20. "Von Eschenbach should move quickly to approve Plan B to show he has the independence needed to be an effective leader of the FDA," the British journal states. FDA has been "stalling" on issuing a decision for the emergency contraceptive for over a year, "apparently to avoid offending antiabortion supporters of President Bush, who claim that the contraceptive is an abortifacient," the piece asserts...